Gracey Craig 4/A

4/A · Omada Health, Inc. · Filed Jul 8, 2026

AI-generated summary of this filing

Updated Jul 9, 2026

Omada Health (OMDA) CAO Gracey Craig Exercises Options & Sells Shares

What Happened

Gracey Craig, Chief Accounting Officer of Omada Health (OMDA), reported same-day option activity and a sale. On 2026-06-12 she exercised options resulting in the acquisition of 6,250 shares at $6.57 per share (total cash paid $41,063). The filing also shows an exercise-related disposition of 6,250 shares reported at $0.00 (derivative). Separately on the same date she sold 6,894 shares in the open market for a weighted-average price of $17.42, generating $120,123 in proceeds.
The sale was executed pursuant to a 10b5-1 trading plan.

Key Details

Transaction date: June 12, 2026.
Option exercise: 6,250 shares acquired at $6.57 (cash paid $41,063); another 6,250 shares reported as disposed at $0.00 (derivative).
Sale: 6,894 shares disposed, weighted-average price $17.42, total proceeds $120,123. Trades executed across $17.04–$17.71 (weighted avg reported). (F3)
Sale executed pursuant to a 10b5-1 trading plan adopted March 13, 2026. (F2)
Filing: This is an amended Form 4/A (filed 2026-07-08) that restates the original Form 4 filed 6/16/2026 to add an exercise that was inadvertently omitted; the corresponding sale was timely reported originally. (F1)
Vesting context: Options follow a 4‑year vesting schedule with 25% vesting after one year and monthly vesting thereafter. (F4)
Shares owned after the reported transactions: adjusted in the amended filing (Box 5); amount not provided here.

Context

This appears to be a same-day exercise-and-sale situation (common when holders exercise options and sell shares immediately). One exercised block is reported as disposed at $0.00—reported as part of the exercise/sale mechanics in the amendment (see footnotes and Form 4/A for detail).
Sales under a 10b5‑1 plan are generally pre-planned and typically viewed as routine insider selling; this filing is informational and does not, by itself, indicate insider sentiment.

Form 4/AAmended

Period: 2026-06-12

Chief Accounting Officer

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-06-12$6.57/sh+6,250$41,063→ 22,335 total
Sale
Common Stock
[F2][F3][F1]
2026-06-12$17.42/sh−6,894$120,123→ 15,441 total
Exercise/Conversion
Stock Option (Right to Buy)
[F1][F4]
2026-06-12−6,250→ 43,750 total
Exercise: $6.57Exp: 2034-10-23→ Common Stock (6,250 underlying)

Footnotes (4)

[F1]This Form 4/A restates in its entirety the original Form 4 filed on 6/16/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.
[F2]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
[F3]This transaction was executed in multiple trades at prices ranging from $17.04 to $17.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F4]25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Signature

/s/ Nathan Salha, as Attorney-in-Fact for Craig Gracey|2026-07-08

1 file